Mario Berger

840 total citations
24 papers, 569 citations indexed

About

Mario Berger is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Mario Berger has authored 24 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Mario Berger's work include Platelet Disorders and Treatments (4 papers), Chronic Kidney Disease and Diabetes (4 papers) and Hormonal Regulation and Hypertension (4 papers). Mario Berger is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Chronic Kidney Disease and Diabetes (4 papers) and Hormonal Regulation and Hypertension (4 papers). Mario Berger collaborates with scholars based in Germany, Netherlands and United Kingdom. Mario Berger's co-authors include Günter J. Hämmerling, Ruth Ganß, Gabriele Bergers, Bernd Arnold, Heide Zerban, Peter Bannasch, Tom H. Lindner, Christoph Wanner, C. M. Schambeck and Martin Llewelyn and has published in prestigious journals such as Circulation, Blood and Kidney International.

In The Last Decade

Mario Berger

22 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Berger Germany 12 136 112 97 82 72 24 569
Claudio Mastruzzo Italy 18 196 1.4× 46 0.4× 88 0.9× 52 0.6× 72 1.0× 29 874
Natthinee Charatcharoenwitthaya Thailand 11 246 1.8× 114 1.0× 74 0.8× 22 0.3× 137 1.9× 18 552
Kimberly E. White United States 10 218 1.6× 131 1.2× 48 0.5× 84 1.0× 53 0.7× 11 708
Marta Vomero Italy 17 339 2.5× 276 2.5× 34 0.4× 93 1.1× 64 0.9× 56 916
Federica Gambelli Italy 13 149 1.1× 32 0.3× 121 1.2× 59 0.7× 58 0.8× 16 595
İbrahım Pirim Türkiye 12 153 1.1× 62 0.6× 52 0.5× 53 0.6× 22 0.3× 59 419
Hiroki Numanami Japan 13 97 0.7× 128 1.1× 135 1.4× 35 0.4× 54 0.8× 41 659
Banu Doğan Gün Türkiye 15 129 0.9× 82 0.7× 237 2.4× 41 0.5× 89 1.2× 62 740
Yolanda Arce Spain 14 207 1.5× 64 0.6× 189 1.9× 71 0.9× 77 1.1× 29 798
Byron Miyazawa United States 15 320 2.4× 80 0.7× 91 0.9× 80 1.0× 50 0.7× 27 834

Countries citing papers authored by Mario Berger

Since Specialization
Citations

This map shows the geographic impact of Mario Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Berger more than expected).

Fields of papers citing papers by Mario Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Berger. The network helps show where Mario Berger may publish in the future.

Co-authorship network of co-authors of Mario Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Berger. A scholar is included among the top collaborators of Mario Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Berger. Mario Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berger, Mario, Aidan MacNamara, Peter Kolkhof, et al.. (2025). Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial. European Heart Journal. 46(34). 3382–3386. 3 indexed citations
2.
Voors, Adriaan A., et al.. (2025). Proteins and signalling pathways targeted by dapagliflozin and finerenone: Insights from DAPA ‐ CKD and FIGARO ‐ DKD. Diabetes Obesity and Metabolism. 28(1). 750–753.
3.
Cunningham, Jonathan W., Brian Claggett, Muthiah Vaduganathan, et al.. (2025). Effects of Finerenone on Natriuretic Peptide Levels in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial. European Journal of Heart Failure. 27(8). 1487–1491. 1 indexed citations
4.
5.
Gansevoort, Ron T., David C. Wheeler, Marijn M. Speeckaert, et al.. (2024). The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial. Nephrology Dialysis Transplantation. 40(6). 1147–1160. 11 indexed citations
6.
Lanktree, Matthew B., Nicolas Perrot, Andrew Smyth, et al.. (2023). A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulation. Kidney International. 104(6). 1170–1184. 12 indexed citations
7.
Berger, Mario, Peter Kolkhof, Richard Nkulikiyinka, et al.. (2023). FIGARO-BM, a Biomarker Study of FIGARO-DKD, Reveals New Insights into the Mode of Action of Finerenone. Journal of the American Society of Nephrology. 34(11S). 16–16. 3 indexed citations
8.
Reenen, Alexander van, Mario Berger, Emmanuel Moreau, et al.. (2019). Analytical performance of a single epitope B-type natriuretic peptide sandwich immunoassay on the Minicare platform for point-of-care diagnostics. Practical Laboratory Medicine. 15. e00119–e00119. 11 indexed citations
9.
Guadiana‐Romualdo, Luis García de, et al.. (2019). Prognostic Performance of Pancreatic Stone Protein in Critically Ill Patients with Sepsis. Biomarkers in Medicine. 13(17). 1469–1480. 19 indexed citations
10.
Barajas, Ramon, Joanna J. Phillips, Scott R. VandenBerg, et al.. (2015). Pro-angiogenic cellular and genomic expression patterns within glioblastoma influences dynamic susceptibility weighted perfusion MRI. Clinical Radiology. 70(10). 1087–1095. 14 indexed citations
11.
Krane, Vera, et al.. (2010). Antibodies to Platelet Factor 4–Heparin Complex and Outcome in Hemodialysis Patients with Diabetes. Clinical Journal of the American Society of Nephrology. 5(5). 874–881. 9 indexed citations
12.
Kulle, Bettina, Beate Luxembourg, Michael Spannagl, et al.. (2008). Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolism. Thrombosis and Haemostasis. 99(11). 905–908. 11 indexed citations
13.
Berger, Mario, Hans H. Stassen, Vera Krane, et al.. (2005). Hidden population substructures in an apparently homogeneous population bias association studies. European Journal of Human Genetics. 14(2). 236–244. 13 indexed citations
14.
Berger, Mario, Gabriele Bergers, Bernd Arnold, Günter J. Hämmerling, & Ruth Ganß. (2005). Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood. 105(3). 1094–1101. 162 indexed citations
15.
Großmann, R., et al.. (2004). High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII. Thrombosis and Haemostasis. 92(7). 42–46. 36 indexed citations
16.
Berger, Mario, Berthold Hocher, Torsten Slowinski, et al.. (2004). Alternative Approach for Rapid and Reliable Single-Nucleotide Polymorphism Typing with Double Restriction Mutagenesis Primer PCR. Clinical Chemistry. 50(12). 2376–2378. 2 indexed citations
17.
Berger, Mario, Manuel Mattheisen, Bettina Kulle, et al.. (2004). High factor VIII levels in venous thromboembolism show linkage to imprinted loci on chromosomes 5 and 11. Blood. 105(2). 638–644. 26 indexed citations
18.
Zerban, Heide, et al.. (2004). Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague–Dawley rats. Toxicology. 206(3). 359–371. 71 indexed citations
19.
Berger, Mario, et al.. (2003). Diabetic Nephropathy: An Inherited Disease or Just a Diabetic Complication?. Kidney & Blood Pressure Research. 26(3). 143–154. 20 indexed citations
20.
Lindner, Tom H., et al.. (2003). Genetic aspects of diabetic nephropathy. Kidney International. 63(84). S186–S191. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Mastruzzo Breakdown of academic impact, for papers by Natthinee Charatcharoenwitthaya Breakdown of academic impact, for papers by Kimberly E. White Breakdown of academic impact, for papers by Marta Vomero Breakdown of academic impact, for papers by Federica Gambelli Breakdown of academic impact, for papers by İbrahım Pirim Breakdown of academic impact, for papers by Hiroki Numanami Breakdown of academic impact, for papers by Banu Doğan Gün Breakdown of academic impact, for papers by Yolanda Arce Breakdown of academic impact, for papers by Byron Miyazawa
Rankless by CCL
2026